Delving into the Latest Updates on Shanghai Yusen New Medicine Development Co.,Ltd. with Synapse

Overview

Tags

Otorhinolaryngologic Diseases

Respiratory Diseases

Mouth and Tooth Diseases

Herbal medicine

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

No Data

Disease Domain	Count

Infectious Diseases	1

Top 5 Drug Type	Count

Herbal medicine	2

1.评价清喉咽含片缩短病程、改善咽痛症状的作用。观察指标：咽痛（吞咽痛）消失率/消失时间、咽痛即时止痛起效率、咽痛 VAS 评分、咽部症状（吞咽痛、咽干灼热）疗效、咽部体征疗效、中医证候疗效等。 2.观察清喉咽含片临床应用的安全性。观察指标：不良事件/不良反应发生率、生命体征、实验室检查等。

[Translation]

1. Evaluate the effect of Qinghou Yan Lozenges in shortening the course of disease and improving pharyngitis symptoms. Observation indicators: pharyngitis (dysphagia) disappearance rate/disappearance time, pharyngitis immediate analgesia efficacy, pharyngitis VAS score, pharyngeal symptoms (dysphagia, dry and burning throat) efficacy, pharyngeal signs efficacy, TCM syndrome efficacy, etc. 2. Observe the safety of Qinghou Yan Lozenges in clinical application. Observation indicators: adverse events/adverse reaction incidence, vital signs, laboratory tests, etc.

Start Date10 Mar 2022

Sponsor / Collaborator

Shanghai Yusen New Medicine Development Co.,Ltd.

CTR20130917 / RecruitingPhase 2

肾力欣颗粒治疗脾肾阳虚、湿瘀互结型慢性肾衰CKD4期有效性和安全性的多中心临床试验

[Translation] A multicenter clinical trial on the efficacy and safety of Shenlixin granules in the treatment of chronic renal failure stage 4 with spleen-kidney yang deficiency and dampness-stasis syndrome

初步评价肾力欣颗粒治疗脾肾阳虚、湿浊兼有血瘀证慢性肾衰CKD4期的有效性和安全性

[Translation]

Preliminary evaluation of the efficacy and safety of Shenlixin granules in the treatment of chronic renal failure (CKD) stage 4 with spleen and kidney yang deficiency, dampness and blood stasis

Start Date21 Nov 2013

Sponsor / Collaborator

Shanghai Yusen New Medicine Development Co.,Ltd.

CTR20170888 / CompletedPhase 2

扶正解毒颗粒治疗急性上呼吸道感染（感冒风热解虚证）有效性和安全性的II期临床试验

[Translation] Phase II clinical trial on the efficacy and safety of Fuzheng Jiedu granules in the treatment of acute upper respiratory tract infection (cold, wind, heat and deficiency syndrome)

对扶正解毒颗粒治疗急性上呼吸道感染（普通感冒风热挟虚证）有效性和安全性进行客观评价。

[Translation]

Objectively evaluate the effectiveness and safety of Fuzheng Jiedu Granules in the treatment of acute upper respiratory tract infection (common cold with wind-heat and deficiency syndrome).

Start Date27 Nov 2012

Sponsor / Collaborator

Shanghai Yusen New Medicine Development Co.,Ltd.

100 Clinical Results associated with Shanghai Yusen New Medicine Development Co.,Ltd.

Login to view more data

0 Patents (Medical) associated with Shanghai Yusen New Medicine Development Co.,Ltd.

Login to view more data

100 Deals associated with Shanghai Yusen New Medicine Development Co.,Ltd.

Login to view more data

100 Translational Medicine associated with Shanghai Yusen New Medicine Development Co.,Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 27 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 2 Clinical

1

Phase 3 Clinical

Other

1

Login to view more data

Current Projects

Drug(Targets)	Indications	Global Highest Phase

Qinghouyan Guccal Tablets	Acute pharyngitis More	Phase 3
Shenlixin Granules	Chronic Kidney Diseases More	Phase 2
Fuzheng Jiedu Granules	Acute upper respiratory infection More	Pending